Literature DB >> 4486485

Biological studies with rosamicin, a new Micromonospora-produced macrolide antibiotic.

J A Waitz, C G Drube, E L Moss, M J Weinstein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4486485     DOI： 10.7164/antibiotics.25.647

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN： 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  16 in total

1.  Rosamicin: in vitro activity against anaerobes and comparison with erythromycin.

Authors:  V L Sutter; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1976-02       Impact factor: 5.191

2.  Antimicrobial activity of several antibiotics and a sulfonamide against Chlamydia trachomatis organisms in cell culture.

Authors:  C C Kuo; S P Wang; J T Grayston
Journal:  Antimicrob Agents Chemother       Date:  1977-07       Impact factor: 5.191

3.  Susceptibility of skin and throat strains of group A streptococci to rosamicin and erythromycin.

Authors:  G Saroglou; A L Bisno
Journal:  Antimicrob Agents Chemother       Date:  1978-04       Impact factor: 5.191

4.  Pharmacokinetics and metabolism of [14C]rosaramicin in dogs.

Authors:  C C Lin; H K Kim; A Marco; E Radwanski; S Symchowicz
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

5.  Rosamicin: evaluation in vitro and comparison with erythromycin and lincomycin.

Authors:  C C Crowe; W E Sanders
Journal:  Antimicrob Agents Chemother       Date:  1974-03       Impact factor: 5.191

6.  Pharmacokinetics and metabolism of rosaramicin in humans.

Authors:  C C Lin; M Chung; R Gural; D Schuessler; H K Kim; E Radwanski; A Marco; C DiGiore; S Symchowicz
Journal:  Antimicrob Agents Chemother       Date:  1984-10       Impact factor: 5.191

7.  Regulation of a macrolide resistance-beta-galactosidase (ermC-lacZ) gene fusion in Escherichia coli.

Authors:  D R Kirsch; M H Lai
Journal:  J Bacteriol       Date:  1984-07       Impact factor: 3.490

8.  In vitro activity of rosamicin and erythromycin against a group of nonfermenting gram-negative bacilli.

Authors:  J R DiPersio; T L Krafczyk
Journal:  Antimicrob Agents Chemother       Date:  1978-08       Impact factor: 5.191

9.  High-pressure liquid chromatographic method for determination of rosaramicin in humans.

Authors:  C Lin; H Kim; D Schuessler; E Oden; S Symchowicz
Journal:  Antimicrob Agents Chemother       Date:  1980-11       Impact factor: 5.191

10.  In vitro activity of rosamicin against Neisseria and Haemophilus, including penicillinase-producing strains.

Authors:  C C Sanders; W E Sanders
Journal:  Antimicrob Agents Chemother       Date:  1977-08       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.